Literature DB >> 15188800

Risk factors for fetal-to-maternal transfusion in Rh D-negative women--results of a prospective study on 942 pregnant women.

Matthias David1, Julia Smidt, Frank C K Chen, Ursula Stein, Joachim W Dudenhausen.   

Abstract

AIMS: To investigate the incidence of severe fetal-to-maternal transfusion after delivery and to identify risk factors.
MATERIAL AND METHODS: In a prospective study at the Department of Obstetrics, Charité, Campus Virchow-Klinikum, Berlin, Germany, we analyzed the incidence of severe fetal-to-maternal transfusion (>10 ml) and fetal-to-maternal hemorrhage (>25 ml) in Rh D-negative pregnant women after delivery of Rh D-positive infants. 942 women were included in the study and Kleihauer-Betke tests were performed. The results were compared to perinatal data.
RESULTS: Fetal-to-maternal hemorrhage occurred in 13 cases out of 942 (incidence of 1.3%) and severe fetal-to-maternal transfusion in 61 cases (6.5%). In all of the cases with fetal-to-maternal hemorrhage, mothers were compatible with their infants in ABO-system. The incidence of fetal-to-maternal transfusion and its severe form was significantly higher in twin pregnancies (7/21 cases and 5/21 cases respectively, 33.3% and 23.8%) than in singleton pregnancies (22.5%, and 5.9%, P<0.001). All other factors, such as maternal age, parity, ethnicity, mode of delivery, presentation, duration of first and second stage of labor, CTG, or Apgar score were not associated with an increased risk of severe fetal-to-maternal transfusion.
CONCLUSIONS: Twin pregnancy is the only independent risk factor for severe fetal-to-maternal transfusion. ABO-incompatibility between mother and infant seems to be protective against Rh D-alloimmunization.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15188800     DOI: 10.1515/JPM.2004.047

Source DB:  PubMed          Journal:  J Perinat Med        ISSN: 0300-5577            Impact factor:   1.901


  6 in total

1.  Demographics, clinical characteristics and outcomes of neonates diagnosed with fetomaternal haemorrhage.

Authors:  Annemarie Stroustrup; Leonardo Trasande
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2012-02-28       Impact factor: 5.747

2.  Demographic and Behavioral Predictors of Severe Fetomaternal Hemorrhage: A Case-Control Study.

Authors:  Annemarie Stroustrup; Callie Plafkin; Thuy-An Tran; David A Savitz
Journal:  Neonatology       Date:  2016-02-10       Impact factor: 4.035

3.  Impact of physician awareness on diagnosis of fetomaternal hemorrhage.

Authors:  Annemarie Stroustrup; Callie Plafkin; David A Savitz
Journal:  Neonatology       Date:  2014-02-08       Impact factor: 4.035

4.  Assessment of feto-maternal hemorrhage among rhesus D negative pregnant mothers using the kleihauer-betke test (KBT) and flow cytometry (FCM) in Addis Ababa, Ethiopia.

Authors:  Fekadu Urgessa; Aster Tsegaye; Yirgu Gebrehiwot; Asaye Birhanu
Journal:  BMC Pregnancy Childbirth       Date:  2014-11-07       Impact factor: 3.007

5.  Risk factors for RhD immunisation despite antenatal and postnatal anti-D prophylaxis.

Authors:  J M Koelewijn; M de Haas; T G M Vrijkotte; C E van der Schoot; G J Bonsel
Journal:  BJOG       Date:  2009-06-17       Impact factor: 6.531

6.  A pilot prospective study of fetomaternal hemorrhage identified by anemia in asymptomatic neonates.

Authors:  A Stroustrup; C Plafkin
Journal:  J Perinatol       Date:  2016-01-14       Impact factor: 2.521

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.